Cancellation Notice Sent To 31 Companies, Including Patanjali, In Mihan-SEZ

Nagpur : The office of the development commissioner (DC) has issued a communication to 31 companies allotted land in Mihan saying that it has been decided to cancel their permission to operate in the SEZ. This includes Patanjali Ayurveda, which has got over 100 acres of land in the SEZ.

The action comes following a review into the status of units in Mihan by the DC’s office. It was found that no records of letters of approval (LOA) were found for 11 companies, but land was shown in their name. For the rest, the LOA had expired, yet the land was in their name.

The LOA is the basic requirement for a unit to operate in an SEZ. In other words, it’s like a licence. The LOA comes from the DC office or Board of Approvals (BOA), in case the investor is a co-developer. Both come under the ministry of commerce. Each SEZ has a DC. The review shows that nearly half of the companies in the SEZ had a valid LOA or did not have one at all, said sources.

Patanjali, which has over 230 acres in the domestic tariff area (DTA) also has 106 acres within the SEZ. The company was allotted land in 2017. The LOA which expired after the first term was not extended, said a source.

Similarly, M/s Vipul Karamchand, a developer is shown to have 54 acres in its name. However, no records of LOA were found, the source said.

This is for the first time such letters have been issued from the DC. Sraman Vasireddy, the DC for Mihan-SEZ, confirmed the development saying that a response has been sought from the companies.

An independent source said this means the units may have to wind up from Mihan-SEZ or else even if the operations are taken up, the tax benefits would not be available. In all these cases, none of the companies has started operations, said sources.

The MADC, which is a state government company, has also been pulled up.

It all began with a review of non-starters. The companies are supposed to start operations within a year of the issuance of LOA. After that, extensions can be issued for 2-3 years. The subsequent extensions have to come from the BOA, said sources.

Five of the companies had taken co-developer status, which means they can let out to other investors. No work was done on the sites, said a source.

Without an LOA, the company ceases to exist in an SEZ. The next step would be to formally strike off these companies names, a source said.

  • Related Posts

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Food regulator FSSAI on Friday said it has suspended the licence of Punjab-based Rehaan Healthcare after it found serious violations of rules at the company’s health supplements and nutraceuticals manufacturing…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun